• info@platform-residras.com

International Registry of Dravet Syndrome and other Syndromes correlated with genes on SCN1A and PCDH19

GW Pharmaceuticals e la società controllata americana Greenwich Biosciences annunciano la pubblicazione di uno studio... GW Pharmaceuticals e la società controllata americana Greenwich Biosciences annunciano la pubblicazione di uno studio di fase 3 relativo a soluzione orale di cannabidiolo nella terapia della sindrome di Lennox-Gastaut nelThe New England Journal of Medicine- Il primo studio con ...
Sudden Death In Dravet May Be Caused by Hyperthermia, SCN1A Defect A combination of high body temperature, seizures and SCN1A mutations could lead to sudden death in Dravet syndrome patients, according to a case report.
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared a link.
Zogenix, Inc. | Therapeutic Solutions for CNS Disorders and Rare Disease Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
Pubblication around ...
Delaying epilepsy onset could reduce impact on development The case of a young boy with a rare genetic disorder over a decade ago has led to a multi-million Euro research project that is raising hopes of new approaches to childhood epilepsy.
Pubblication around Dravet Syndrome and Drug Resistant ...
Ketogenic Diet Therapy in Infants: Efficacy and Tolerability. - PubMed - NCBI https://www.ncbi.nlm.nih.gov/m/pubmed/29610033/
Pediatr Neurol. 2018 Jan 31. pii: S0887-8994(17)30931-1. doi: 10.1016/j.pediatrneurol.2017.10.018. [Epub ahead of print]
Stoke's Dravet Syndrome Therapy Shows Promise in Mouse Study Read about a treatment approach that Stoke Therapeutics is developing for Dravet syndrome and other genetic disorders showing promise in mice.
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared a link.
Error - PubMed - NCBI https://www.ncbi.nlm.nih.gov/pubmed/?cmd=historysearch&querykey=2
PubMed comprises more than 28 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Antiepileptic drug treatment of generalized tonic–clonic seizures: An evaluation of regulatory data and five criteria... https://www.sciencedirect.com/science/article/pii/S1525505017310727#.WrnONS3zB58.twitter
A generalized tonic–clonic seizure (GTCS) is the most severe form of common epileptic seizure and carries the greatest risk of harm. The aim of this review is to provide an evidence-based guide for the selection of antiepileptic drugs (AEDs) ...
Seizure Freedom in Patients With Dravet Syndrome With Contraceptives: A Case Report With Two Patients... Dravet syndrome is a rare and malignant epileptic syndrome that is typically resistant to antiepileptic drugs. There is a growing interest in the antiepileptic properties of neurosteroids. Especially progesterone is known to act as an anticonvulsive agent. However, contraceptives that ...
Stiripentol efficacy and safety in Dravet syndrome: a 12‐year observational study http://onlinelibrary.wiley.com/doi/10.1111/dmcn.13704/abstract;jsessionid=CC3C94B47752C591DBCB7E07CE8420B7.f01t04
To assess long‐term safety and efficacy of stiripentol as an antiepileptic medication for people with Dravet syndrome.A prospective, observational open‐label study (2003–2015) of the efficacy and long‐term...
Epilepsy genetics in 2018 – Three things that will happen and three things that won’t Bomb Cyclone. While the entire US East Cost was held hostage by a weather system that introduced us to new catchy meterological concepts such as bombogenesis, I hope that everybody is staying warm …
Pubblication around Dravet Syndrome and Drug ...
Rare Disease Report Zogenix, Inc. announced today that the last patient has been randomized into the treatment period of Study 1504, its second Phase 3 clinical trial evaluating ZX008 (low-dose fenfluramine) as an adjunctive treatment for seizures in children and young adults with ...

Load More